tianjin farto international industry limited

COMPOSITION:

Contains per ml:

Buparvaquone................................................50mg

Solvents ad......................................................1ml

DESCRIPTION:

Buparvaquone is a second-generation hydroxynaphtaquinone with nover features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis.

INDICATION:

For treatment of tick-transmitted theileriosis caused by the intracellular protozoan parasites theileria

Parva(East coast fever,Corridor disease,Zimbabwean theileriosis)and T.annulata(tropical theileriosis)in cattle,it is active against both the schizont and piroplasm stages of Theileriaspp., and may be used during the incubation period of the disease.or when clinical signs are apparent.

CONTRA INDICATIONS:

Due to the inhibiting effects of theileriosis on the immune system,vaccination should be delayed until the animal has recovered from theileriosis.

SIDE EFFECTS:

Localised,painless.oedematous swelling may occasionally be seen at the injection site.

DOSAGE:

For intramuscular injection.

The general dosage is 1 ml per 20kg body weight.

In severe cases the treatment may be repeated within 48-72hours.

Do not administer more than 10ml per injection site.

Successive injection should be administered at different sites

WITHDRAWAL TIMES:

For meat:42days

For milk:2days

WARNING:

Keep out of reach of children.

Packing:glass vial of 50ml